![]() |
Comparison of DPP-4 Inhibitors.
Nam Hoon Kim, Sin Gon Kim
J Korean Diabetes. 2013;14(3):111-119. Published online 2013 Sep 30 DOI: https://doi.org/10.4093/jkd.2013.14.3.111
|
Citations to this article as recorded by
Signal Detection of DPP-IV Inhibitors using Spontaneous Adverse Event Reporting System in Korea
Hyejung Pyo, Tae Young Kim, Su Been Choi, Hyeong Jun Jo, Hae Lee Kang, Jung Sun Kim, Hye Sun Gwak, Ji Min Han
Korean Journal of Clinical Pharmacy.2024; 34(2): 100. CrossRef Efficacy and Tolerability of Evogliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis with Bayesian Inference Through a Quality-management System
Hojin Oh, Hai Duc Nguyen, In Mo Yoon, Min-Sun Kim
Clinical Therapeutics.2021; 43(8): 1336. CrossRef Metformin combined with dipeptidyl peptidase-4 inhibitors or metformin combined with sulfonylureas in patients with type 2 diabetes: A real world analysis of the South Korean national cohort
Yeon Young Cho, Sung-Il Cho
Metabolism.2018; 85: 14. CrossRef
|